These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6717705)

  • 1. High-density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome.
    Sokolovskaya IV; Nikiforova NV
    Nephron; 1984; 37(1):49-53. PubMed ID: 6717705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [alpha-Lipoprotein cholesterol content of the blood serum in nephrotic syndrome].
    Nikiforova NV; Sokolovskaia IV; Riaposova IK; Poliantseva LR
    Ter Arkh; 1982; 54(7):57-61. PubMed ID: 7135225
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome.
    Chan MK; Persaud JW; Varghese Z; Moorhead JF
    Aust N Z J Med; 1984 Dec; 14(6):841-7. PubMed ID: 6598053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
    Joven J; Rubiés-Prat J; Espinel E; Ras MR; Piera L
    Nephrol Dial Transplant; 1987; 2(3):149-53. PubMed ID: 3114674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High density lipoproteinuria in nephrotic syndrome.
    de Mendoza SG; Kashyap ML; Chen CY; Lutmer RF
    Metabolism; 1976 Oct; 25(10):1143-9. PubMed ID: 184367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum lipoprotein abnormalities in patients with nephrotic syndrome and effects of steroid therapy].
    Kohtoku N; Okuda F; Shimizu K; Takagi H; Fujii Z; Fujii H; Kusukawa R
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):335-44. PubMed ID: 2747006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO; Agbedana EO; Kadiri S; Taylor GO
    Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria.
    Saku K; Mendoza SG; Laver M; Hynd BA; Gartside PS; Kashyap ML
    Nephron; 1988; 50(2):112-5. PubMed ID: 3146703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK; Arora RC; Agarwal N; Garg RK; Arora S; Gurbaxani RK; Sharma D
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study.
    Jin K; Park BS; Kim YW; Vaziri ND
    Am J Kidney Dis; 2014 Apr; 63(4):584-9. PubMed ID: 24315769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome.
    Jüngst D; Caselmann WH; Kutschera P; Weisweiler P
    Clin Chim Acta; 1987 Sep; 168(2):159-67. PubMed ID: 3677414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid metabolism in the nephrotic syndrome].
    Tesar V; Merta M; Poledne R; Tĕmínová J; Zima T; Rychlík I; Zabka J; Stejskalová A
    Sb Lek; 1996; 97(1):143-50. PubMed ID: 8711410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M; Taş S; Sarandöl E; Tokullugil HA
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.